Sep 16 Purdue Pharma files for bankruptcy as part of opioids settlement By Geoff Mulvihill, Associated Press The bankruptcy filing was anticipated before and after a tentative settlement deal, which could be worth up to $12 billion over time, was struck. Continue reading
Sep 14 NY finds $1B in hidden transfers by family behind OxyContin By Adam Geller, Associated Press The family that owns OxyContin maker Purdue Pharma used Swiss and other hidden accounts to transfer $1 billion to themselves, New York's attorney general contends in court papers filed Friday. Continue reading
Sep 12 Some states say they’ll keep fighting Purdue Pharma in court By Geoff Mulvihill, Dave Collins, Associated Press Courtroom showdowns still face OxyContin maker Purdue Pharma and the family that owns it, the Sacklers. But after a tentative settlement reached Wednesday with thousands of local governments and more than 20 states, the fight will be less about the… Continue reading
Sep 11 Watch 6:49 $3 billion from Sacklers ‘just a down payment’ on opioid debt, says Conn. attorney general The American opioid crisis has left a lethal mark. Experts estimate as many as 400,000 people may have died from overdoses and related problems in the past several decades. Now, more than 20 states appear to have reached a comprehensive… Continue watching
Sep 11 OxyContin maker agrees to tentative settlement, attorneys say By Geoff Mulvihill, Dave Collins, Associated Press Attorneys representing some 2,000 local governments say they have agreed to a tentative settlement with OxyContin maker Purdue Pharma over the toll of the nation's opioid crisis. Continue reading
Sep 08 A Purdue bankruptcy would make opioids cases even messier By Geoff Mulvihill, Associated Press State and local governments have sought billions of dollars from Purdue Pharma as a way to hold the company and the family that owns it accountable for the nation's opioid epidemic, a potential payout that is now clouded in uncertainty… Continue reading
Aug 28 OxyContin maker negotiating settlement worth a reported $12B By Andrew Welsh-Huggins, Associated Press Purdue Pharma, the maker of the prescription painkiller OxyContin, is facing billions of dollars in potential liability for its role in the nation's opioid crisis. Continue reading
Aug 26 Watch 8:01 What Okla. judgment against Johnson & Johnson means for opioid accountability An Oklahoma judge delivered a $572 million judgment against pharmaceutical giant Johnson & Johnson in the first major legal decision to go against a drugmaker for its role in the opioid crisis. The judge found the company’s marketing practices helped… Continue watching
Apr 04 Oklahoma drops some claims in lawsuit against opioid manufacturers By Tim Talley, Associated Press The state attorney general's office will continue to pursue allegations that the drugmakers created a public nuisance, which he says is the most important allegation against the drugmakers. Continue reading
Apr 02 Family behind OxyContin calls Massachusetts opioid suit false, misleading By Geoff Mulvihill, Alanna Durkin Richer, Associated Press The Sackler family says a lawsuit filed by Massachusetts Attorney General Maura Healey that accuses Connecticut-based Purdue Pharma and the family of hiding the risks of opioids from doctors and patients is riddled with inaccurate and misleading statements. Continue reading